Reversal of inflammatory reprogramming by vasodilator agents in pulmonary hypertension.
Kirillova A, Sethuraman M, Dong X, Kirdar A, Speyer G, Al Aaraj Y, Watson A, Schneider LK, Creager MD, Lafyatis R, Okawa S, Kim S, Chan SY.
Kirillova A, et al. Among authors: kim s.
ERJ Open Res. 2025 Jan 13;11(1):00486-2024. doi: 10.1183/23120541.00486-2024. eCollection 2025 Jan.
ERJ Open Res. 2025.
PMID: 39811555
Free PMC article.